Etude des effets de l'enoximone sur la sensibilité du chémorécepteur.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-004066-14-BE

Enrollment

Registered

2006-07-28

Start date

2006-08-22

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

Trade Name: Perfan Product Name: perfan Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: ENOXIMONE CAS Number: 77671319 Concentration unit: mg milligram(s) Concentration

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy subjects no medication age 18-35 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: assess the effects of enoximone on chemoreflex sensitivity;Secondary Objective: ;Primary end point(s):	—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026